Bayer is ready to pour billions more into its pharma manufacturing operations, but with that, it will cut ties with several sites it already owns. Bayer will invest more than $2.26 billion in its pharmaceutical manufacturing over the next three years, as it expands in both Europe and the US. Expansions in Bergkamen, Berlin, Leverkusen, … Continue reading Bayer to dump $2.26B into manufacturing realignment as it says goodbye to some sites